Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5.8% After Analyst Upgrade
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) rose 5.8% on Friday after Jefferies Financial Group raised their price target on the stock from $54.00 to $58.00. Jefferies Financial Group currently has a buy rating on the stock. Tarsus Pharmaceuticals traded as high as $44.97 and last traded at $46.08. Approximately 23,253 shares […]
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) rose 5.8% on Friday after Jefferies Financial Group raised their price target on the stock from $54.00 to $58.00. Jefferies Financial Group currently has a buy rating on the stock. Tarsus Pharmaceuticals traded as high as $44.97 and last traded at $46.08. Approximately 23,253 shares […]
